drugset / Trial / NCT01549106

IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study

NCT01549106

Phase 1 Completed 106 enrolled SecuraBio
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IPI-145 after single and repeat oral administration, and to evaluate the effects of food and ketoconazole on the plasma pharmacokinetics of IPI-145.

Timeline

Start
2011-08
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Duvelisib Small molecule Oral

Indications

No indication recorded.